Literature DB >> 11750242

Natural history of benign prostatic hyperplasia.

S J Jacobsen1, C J Girman, M M Lieber.   

Abstract

Studies in varied settings have provided estimates of the prevalence of surrogate markers of benign prostatic hyperplasia (BPH). In population-based studies, the prevalence of moderate-to-severe lower urinary tract symptoms and depressed peak urinary flow rates increases across successively older age groups. Prostatic volume follows a similar pattern. Unlike clinic-based studies in which correlations are almost nonexistent, the population-based studies demonstrate a modest correlation among lower urinary tract symptoms, peak urinary flow rates, and prostatic volume. These cross-sectional observations extend to serum prostate-specific antigen levels and postvoid residual urine volumes. Data collected during the longitudinal follow-up study of men participating in the Olmsted County Study of Urinary Symptoms and Health Status Among Men provide a more detailed description of the natural history of changes in these surrogate markers of BPH. They also provide insights into their relation with each other and with long-term outcomes of BPH, such as acute urinary retention and treatment of BPH. These data demonstrate the progressive nature of BPH and are useful for the design and interpretation of clinical trials. Furthermore, they suggest that observational studies of etiology and prognosis should take advantage of the spectrum of disease reflected by the full range of values of these quantitative traits, rather than an arbitrary dichotomized outcome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11750242     DOI: 10.1016/s0090-4295(01)01298-5

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  44 in total

1.  [Urological illnesses in the elderly].

Authors:  J M Wolff
Journal:  Urologe A       Date:  2004-08       Impact factor: 0.639

2.  Optimizing the management of benign prostatic hyperplasia.

Authors:  Dean S Elterman; Jack Barkin; Steven A Kaplan
Journal:  Ther Adv Urol       Date:  2012-04

3.  How important are men's lower urinary tract symptoms (LUTS) and their impact on the quality of life (QOL)?

Authors:  J Haltbakk; B R Hanestad; S Hunskaar
Journal:  Qual Life Res       Date:  2005-09       Impact factor: 4.147

Review 4.  Male overactive bladder: the role of urodynamics and anticholinergics.

Authors:  Scott MacDiarmid; Alexandra Rogers
Journal:  Curr Urol Rep       Date:  2007-01       Impact factor: 3.092

Review 5.  Acute urinary retention: who is at risk and how best to manage it?

Authors:  Anand Patel; Christopher Chapple
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

6.  Pathophysiology of lower urinary tract symptoms in the aging male population.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2005

7.  Pathophysiology of benign prostatic hyperplasia in the aging male population.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2005

Review 8.  Use of 5alpha-reductase inhibitors to prevent benign prostatic hyperplasia disease.

Authors:  Leonard S Marks
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

9.  Incidence, predictors, and associated outcomes of prostatism after kidney transplantation.

Authors:  Frank P Hurst; Robert T Neff; Edward M Falta; Rahul M Jindal; Krista L Lentine; John S Swanson; Lawrence Y Agodoa; Kevin C Abbott
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-28       Impact factor: 8.237

10.  A signaling network in phenylephrine-induced benign prostatic hyperplasia.

Authors:  Jayoung Kim; Yutaka Yanagihara; Tadahiko Kikugawa; Mihee Ji; Nozomu Tanji; Yokoyama Masayoshi; Michael R Freeman
Journal:  Endocrinology       Date:  2009-05-14       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.